Prize-Winning PhD

By Karen Hopkin Prize-Winning PhD Aaron Ciechanover didn’t set out to win a Nobel Prize for discovering ubiquitin’s all-important role in protein degradation. He was just trying to graduate. © Dan Porges Aaron Ciechanover could not have predicted that the humble system he was studying would play a central role in everything that happens from embryonic development to adulthood. Of course he was just a graduate student at the time. ̶

Written byKaren Hopkin
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Aaron Ciechanover could not have predicted that the humble system he was studying would play a central role in everything that happens from embryonic development to adulthood. Of course he was just a graduate student at the time. “We didn’t set out to identify ubiquitin. We didn’t know anything about ubiquitin or its function,” says Ciechanover of the discovery that earned him and his mentors the 2004 Nobel Prize in Chemistry. “We were studying intracellular proteolysis and we bumped into it.”

These days, even undergrads know that eukaryotic cells use ubiquitin as a sort of molecular “kiss of death” to mark its damaged proteins for destruction. What’s more, death-by-ubiquitination serves as a key mechanism for controlling tightly regulated cellular processes from cell division to cell death. But in the late 1970s, the notion that cells willfully discard their proteins was not a very popular one. “If you thought protein breakdown ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies